George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 184.50
Bid: 185.00
Ask: 185.30
Change: -0.80 (-0.43%)
Spread: 0.30 (0.162%)
Open: 186.50
High: 187.40
Low: 184.20
Prev. Close: 185.30
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Direct Line Insurance Group plc

25 Mar 2024 09:18

RNS Number : 1423I
Societe Generale SA
25 March 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Direct Line Insurance Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22/03/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes: Ageas SA/NV

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

Ordinary 10 10/11p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

29,413,762

2.24

40,876

0.00

(2) Cash-settled derivatives:

 

0

0.00

1,221,302

0.09

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

29,413,762

2.24

1,262,178

0.10

 

 

 

 

 

 

 

 

 

All interests and all short positions should be disclosed.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

EUR

Ordinary 10 10/11p

Purchase

2,400

2.21

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GBP

Ordinary 10 10/11p

Purchase

6,309

2.09428

Ordinary 10 10/11p

Purchase

815

2.09

Ordinary 10 10/11p

Purchase

840

2.09

Ordinary 10 10/11p

Purchase

2,645

2.09

Ordinary 10 10/11p

Purchase

4,734

2.09

Ordinary 10 10/11p

Purchase

11,801

2.09

Ordinary 10 10/11p

Purchase

17,287

2.09

Ordinary 10 10/11p

Purchase

17,980

2.09

Ordinary 10 10/11p

Purchase

2,648

2.123

Ordinary 10 10/11p

Purchase

14

2.11

Ordinary 10 10/11p

Purchase

116

2.121

Ordinary 10 10/11p

Purchase

161

2.11

Ordinary 10 10/11p

Purchase

198

2.121

Ordinary 10 10/11p

Purchase

218

2.121

Ordinary 10 10/11p

Purchase

588

2.11

Ordinary 10 10/11p

Purchase

616

2.105

Ordinary 10 10/11p

Purchase

678

2.105

Ordinary 10 10/11p

Purchase

701

2.11

Ordinary 10 10/11p

Purchase

744

2.105

Ordinary 10 10/11p

Purchase

744

2.11

Ordinary 10 10/11p

Purchase

1,200

2.124

Ordinary 10 10/11p

Purchase

1,325

2.106

Ordinary 10 10/11p

Purchase

1,862

2.11

Ordinary 10 10/11p

Purchase

2,019

2.136

Ordinary 10 10/11p

Purchase

2,023

2.124

Ordinary 10 10/11p

Purchase

2,025

2.122

Ordinary 10 10/11p

Purchase

2,027

2.12

Ordinary 10 10/11p

Purchase

2,030

2.118

Ordinary 10 10/11p

Purchase

2,037

2.111

Ordinary 10 10/11p

Purchase

2,038

2.105

Ordinary 10 10/11p

Purchase

2,048

2.095

Ordinary 10 10/11p

Purchase

2,096

2.119

Ordinary 10 10/11p

Purchase

2,358

2.119

Ordinary 10 10/11p

Purchase

3,948

2.152

Ordinary 10 10/11p

Purchase

4,039

2.154

Ordinary 10 10/11p

Purchase

4,233

2.149

Ordinary 10 10/11p

Sale

6,600

2.09

Ordinary 10 10/11p

Sale

209,992

2.09

Ordinary 10 10/11p

Sale

30,137

2.09

Ordinary 10 10/11p

Sale

4,421

2.0901

Ordinary 10 10/11p

Sale

569

2.138

Ordinary 10 10/11p

Sale

1,131

2.138

Ordinary 10 10/11p

Sale

1,662

2.118

Ordinary 10 10/11p

Sale

247

2.118

Ordinary 10 10/11p

Sale

1,700

2.118

Ordinary 10 10/11p

Sale

1,982

2.138

Ordinary 10 10/11p

Sale

49

2.118

Ordinary 10 10/11p

Sale

86

2.118

Ordinary 10 10/11p

Sale

88

2.118

Ordinary 10 10/11p

Sale

99

2.118

Ordinary 10 10/11p

Sale

210

2.138

Ordinary 10 10/11p

Sale

273

2.118

Ordinary 10 10/11p

Sale

371

2.138

Ordinary 10 10/11p

Sale

452

2.138

Ordinary 10 10/11p

Sale

652

2.138

Ordinary 10 10/11p

Sale

1,064

2.118

Ordinary 10 10/11p

Sale

25

2.124

Ordinary 10 10/11p

Sale

224

2.138

Ordinary 10 10/11p

Sale

424

2.116

Ordinary 10 10/11p

Sale

848

2.124

Ordinary 10 10/11p

Sale

1,515

2.139

Ordinary 10 10/11p

Sale

1,607

2.116

Ordinary 10 10/11p

Sale

1,700

2.124

Ordinary 10 10/11p

Sale

1,822

2.139

Ordinary 10 10/11p

Sale

2,000

2.155

Ordinary 10 10/11p

Sale

2,029

2.118

Ordinary 10 10/11p

Sale

2,205

2.138

Ordinary 10 10/11p

Sale

2,458

2.118

Ordinary 10 10/11p

Sale

3,018

2.137

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

Ordinary 10 10/11p

CFD

Increasing a short position

6,309

2.09428

Ordinary 10 10/11p

CFD

Reducing a short position

6,600

2.09

Ordinary 10 10/11p

CFD

Reducing a short position

209,992

2.09

Ordinary 10 10/11p

CFD

Reducing a short position

30,137

2.09

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

25/03/2024

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETQKPBDCBKKANB
Date   Source Headline
26th Apr 202412:00 pmRNSHolding(s) in Company
10th Apr 20247:00 amRNSDirect Line Group to appoint new CFO
9th Apr 20245:00 pmRNSDirector/PDMR Shareholding
9th Apr 20244:00 pmRNSHolding(s) in Company
8th Apr 20246:00 pmRNSDirector/PDMR Shareholding
8th Apr 20242:00 pmRNS2023 Solvency and Financial Condition Report
8th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 202412:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:11 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
28th Mar 20246:15 pmRNSDirector/PDMR Shareholding
28th Mar 20246:00 pmRNSDirector/PDMR Shareholding
28th Mar 20248:15 amRNSAnnual Financial Report
27th Mar 20241:28 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
26th Mar 20242:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20241:49 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Mar 20241:47 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
26th Mar 20241:43 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 202411:23 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
26th Mar 202411:14 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
26th Mar 202411:13 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
26th Mar 20247:29 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20245:06 pmRNSDIRECT LINE _8.5 EPT NON-RI_UK_BOFASE_Replacement
25th Mar 20243:21 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
25th Mar 20243:12 pmRNSForm 8.5(EPT/RI)-Direct Line Insurance Group Amend
25th Mar 20243:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20243:00 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:00 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20242:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
25th Mar 20242:20 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20242:17 pmRNSForm 8.3 -Direct Line Insurance Group plc
25th Mar 20242:08 pmRNSForm 8.3 - Ageas SA NV
25th Mar 20241:55 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20241:26 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20241:10 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
25th Mar 202412:17 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 202411:37 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
25th Mar 202410:30 amRNSDIRECT LINE INSURANCE_8.5 EPT RI_UK_MLI
25th Mar 202410:29 amRNSDIRECT LINE INSURANCE_8.5 EPT NON-RI_UK_BOFASE
25th Mar 20249:18 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20249:10 amRNSForm 8.5 (EPT/RI)- Direct Line Insurance Group plc
22nd Mar 20246:28 pmRNSResponse to Rule 2.8 termination announcement
22nd Mar 20246:22 pmRNSStatement re No Intention to Make an Offer
22nd Mar 20243:59 pmRNSForm 8.3 - Ageas SA/NV
22nd Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
22nd Mar 20243:06 pmRNSForm 8.3 - Direct Line Insurance Group Plc
22nd Mar 20243:00 pmRNSForm 8.3 - Ageas SA/NV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.